Z, W., Q, W., Y, Y., M, C., J, D., Y, X., . . . J, L. (2026). Targeting the RNA acetyltransferase NAT10 attenuates pulmonary fibrosis via the ac4C-mediated regulation of the C/EBPβ-ITGA11 axis. International immunopharmacology, 181, 116793. https://doi.org/10.1016/j.intimp.2026.116793
Chicago Style (17th ed.) CitationZ, Wang, Wu Q, Yao Y, Cao M, Ding J, Xiao Y, Huang X, and Luo J. "Targeting the RNA Acetyltransferase NAT10 Attenuates Pulmonary Fibrosis via the Ac4C-mediated Regulation of the C/EBPβ-ITGA11 Axis." International Immunopharmacology 181 (2026): 116793. https://doi.org/10.1016/j.intimp.2026.116793.
MLA (9th ed.) CitationZ, Wang, et al. "Targeting the RNA Acetyltransferase NAT10 Attenuates Pulmonary Fibrosis via the Ac4C-mediated Regulation of the C/EBPβ-ITGA11 Axis." International Immunopharmacology, vol. 181, 2026, p. 116793, https://doi.org/10.1016/j.intimp.2026.116793.